- Home
- LTM vs BIO Comparison
LTM vs BIO Comparison
Compare LTM & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LTM
- BIO
- Stock Information
- Founded
- LTM 1929
- BIO 1952
- Country
- LTM Chile
- BIO United States
- Employees
- LTM N/A
- BIO N/A
- Industry
- LTM
- BIO Biotechnology: Laboratory Analytical Instruments
- Sector
- LTM
- BIO Industrials
- Exchange
- LTM NYSE
- BIO Nasdaq
- Market Cap
- LTM 8.2B
- BIO 9.6B
- IPO Year
- LTM N/A
- BIO N/A
- Fundamental
- Price
- LTM $27.63
- BIO $353.91
- Analyst Decision
- LTM Strong Buy
- BIO Strong Buy
- Analyst Count
- LTM 3
- BIO 4
- Target Price
- LTM $38.00
- BIO $414.00
- AVG Volume (30 Days)
- LTM 129.9K
- BIO 154.6K
- Earning Date
- LTM 01-01-0001
- BIO 02-13-2025
- Dividend Yield
- LTM 0.00%
- BIO N/A
- EPS Growth
- LTM N/A
- BIO N/A
- EPS
- LTM 0.00
- BIO N/A
- Revenue
- LTM $12,707,202,000.00
- BIO $2,580,209,000.00
- Revenue This Year
- LTM $13.23
- BIO N/A
- Revenue Next Year
- LTM $6.85
- BIO $2.92
- P/E Ratio
- LTM $10.55
- BIO N/A
- Revenue Growth
- LTM 14.06
- BIO N/A
- 52 Week Low
- LTM $21.83
- BIO $262.12
- 52 Week High
- LTM $29.13
- BIO $387.99
- Technical
- Relative Strength Index (RSI)
- LTM N/A
- BIO 61.58
- Support Level
- LTM N/A
- BIO $334.57
- Resistance Level
- LTM N/A
- BIO $355.05
- Average True Range (ATR)
- LTM 0.00
- BIO 10.56
- MACD
- LTM 0.00
- BIO 1.65
- Stochastic Oscillator
- LTM 0.00
- BIO 96.44
About LTM LATAM AIRLINES GROUP SA SPON ADS EACH REP 2000 SHS
LATAM Airlines Group SA operates as a passenger airline group. Geographically, the company operates in Brazil, Chile, Colombia, Ecuador, and Peru, along with international operations within Latin America and to Europe, the US, and the Caribbean. The firm generates its revenue from transporting passengers and cargo.
About BIO Bio-Rad Laboratories Inc.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.